Hostname: page-component-586b7cd67f-l7hp2 Total loading time: 0 Render date: 2024-11-20T13:25:58.690Z Has data issue: false hasContentIssue false
  • English
  • Français

Monitoring the physical health of individuals with serious mental illness

Published online by Cambridge University Press:  13 June 2014

Majella Cahill  and
Anne Jackson
Majella Cahill*
Affiliation:
Navan Sector Psychiatric Services, Co Meath
Anne Jackson
Affiliation:
Navan Sector Psychiatric Services, Co Meath
*
Correspondence E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Developing effective models of identifying and managing physical ill health amongst mental health service users has become an increasing concern for psychiatric service providers. This article sets out the general professional and Irish statutory obligations to provide physical health monitoring services for individuals with serious mental illness. Review and summary statements are provided in relation to the currently available guidelines on physical health monitoring.

Keywords

Service developmentPhysical health monitoringSerious mental illness (SMI)Irish.
Type
Review
Information
Irish Journal of Psychological Medicine , Volume 25 , Issue 3 , September 2008 , pp. 108 - 115
Copyright
Copyright © Cambridge University Press 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Kisely, S, Smith, M, Lawrence, D, Maaten, S. Mortality in individuals who have had psychiatric treatment: population-based study in Nova Scotia. Br J Psychiatry 2005; 187:552–558.CrossRefGoogle ScholarPubMed
2.Hansen, V, Jacobsen, BK, Arnesen, E. Cause-specific mortality in psychiatric patients after deinstitutionalisation. Br J Psychiatry 2001; 179: 438–443.CrossRefGoogle ScholarPubMed
3.Lawrence, DM, Holman, CD, Jablensky, AV, Hobbs, MS. Death rate from ischaemic heart disease in Western Australian psychiatric patients 1980-1998. Br J Psychiatry 2003; 182:31–36.CrossRefGoogle ScholarPubMed
4.Rasanen, S, Hakko, H, Viilo, K, Meyer-Rochow, VB, Moring, J. Excess mortality among long-stay psychiatric patients in Northern Finland. Soc Psychiatry Psychiatr Epidemiol 2003; 38(6): 297–304.CrossRefGoogle ScholarPubMed
5.Hannerz, H, Borga, P, Borritz, M. Life expectancies for individuals with psychiatric diagnoses. Public Health 2001; 115(5): 328–337.CrossRefGoogle ScholarPubMed
6.Jones, DR, Macias, C, Barreira, PJ, Fisher, WH, Hargreaves, WA, Harding, CM. Prevalence, severity, and co-occurrence of chronic physical health problems of persons with serious mental illness. Psychiatr Serv 2004; 55(11): 1250–1257.CrossRefGoogle ScholarPubMed
7.Dickey, B, Normand, SL, Weiss, RD, Drake, RE, Azeni, H. Medical morbidity, mental illness, and substance use disorders. Psychiatr Serv 2002; 53(7): 861–867.CrossRefGoogle ScholarPubMed
8.Dembling, BP, Chen, DT, Vachon, L. Life expectancy and causes of death in a population treated for serious mental illness. Psychchiatr Serv 1999; 50(8): 1036–1042.CrossRefGoogle Scholar
9.Lucksted, A, McGuire, C, Postrado, L, Kreyenbuhl, J, Dixon, LB. Specifying cigarette smoking and quitting among people with serious mental illness. Am J Addict 2004; 13(2): 128–38.CrossRefGoogle ScholarPubMed
10.McCreadie, RG, Scottish Schizophrenia lifestyle group. Diet, smoking and cardiovascular risk in people with schizophrenia: descriptive study. B J Psychiatry 2003; 183:534–539.Google ScholarPubMed
11.Henderson, DCet al.Dietary intake profile of patients with schizophrenia. Ann Clin Psychiatry 2006; 18(2): 99–105.CrossRefGoogle ScholarPubMed
12.Daumit, GLet al.Physical activity patterns in adults with severe mental illness. J Nerv Ment Dis 2005; 193(10): 641–646.CrossRefGoogle ScholarPubMed
13.Ryan, MC, Collins, P, Thakore, JH. Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia. Am J Psychiatry 2003; 160(2): 284–289.CrossRefGoogle ScholarPubMed
14.Newcomer, JW. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. CNS Drugs 2005; 19(Suppl 1): 1–93.CrossRefGoogle ScholarPubMed
15.Marder, SRet al.Physical health monitoring of patients with schizophrenia. Am J Psychiatry 2004; 161 (8): 1334–49.CrossRefGoogle ScholarPubMed
16.Druss, BG, Rosenheck, RA. Use of medical services by veterans with mental disorders. Psychosomatics 1997; 38(5): 451–458.CrossRefGoogle ScholarPubMed
17.Kilbourne, AM, McCarthy, JF, Welsh, D, Blow, F. Recognition of co-occurring medical conditions among patients with serious mental illness. J Nerv Ment Dis 2006; 194 (8): 598–602.CrossRefGoogle ScholarPubMed
18.Pratt, SI, Mueser, KT, Driscoll, M, Wolfe, R, Battels, SJ. Medication non-adherence in older people with serious mental illness: prevalence and correlates. Psychiatr Rehabil J 2006; 29 (4): 299–310.CrossRefGoogle ScholarPubMed
19.Wagner, GJ, Kanouse, DE, Koegel, P, Sullivan, G. Correlates of HIV antiretroviral adherence in persons with serious mental illness. AIDS Care 2004; 16 (4): 501–506.CrossRefGoogle ScholarPubMed
20.Bane, C, Hughes, CM, McElnay, JC. The impact of depressive symptoms and psychosocial factors on medication adherence in cardiovascular disease. Patient Educ Couns 2006; 60 (2): 187–193.CrossRefGoogle ScholarPubMed
21.Salsberry, PJ, Chipps, E, Kennedy, C. Use of general medical services among Medicaid patients with severe and persistent mental illness. Psychiatr Serv 2005; 56 (4): 458–462.CrossRefGoogle ScholarPubMed
22.Cradock-O'Leary, J, Young, AS, Yano, EM, Wang, M, Lee, ML. Use of general medical services by VA patients with psychiatric disorders. Psychiatr Serv 2002; 53(7): 874–878.CrossRefGoogle ScholarPubMed
23.Himelhoch, S, Weller, WE, Wu, AW, Anderson, GF, Cooper, LA. Chronic medical illness, depression, and use of acute medical services among Medicare beneficiaries. Med Care 2004; 42(6): 512–521.CrossRefGoogle ScholarPubMed
24.Sullivan, G, Han, X, Moore, S, Kotria, K. Disparities in hospitalization for diabetes among persons with and without co-occurring mental disorders. Psychiatr Serv 2006; 57(8): 1126–1131.CrossRefGoogle ScholarPubMed
25.Frayne, SMet al.Disparities in diabetes care: impact of mental illness. Arch Intern Med 2005; 165(22): 2631–2638.CrossRefGoogle ScholarPubMed
26.Petersen, LA, Normand, SL, Druss, BG, Rosenheck, RA. Process of care and outcome after acute myocardial infarction for patients with mental illness in the VA health care system: are there disparities? Health Serv Res 2003; 38(1 Ft 1): 41–63.CrossRefGoogle ScholarPubMed
27.Druss, BG, Bradford, DW, Rosenheck, RA, Radford, MJ, Krumholz, HM. Mental disorders and use of cardiovascular procedures after myocardial infarction. JAMA. 2000; 283(4): 506–11.CrossRefGoogle ScholarPubMed
28.Chwastiak, LA, Rosenheck, RA, McEvoy, JP, Keefe, RS, Swartz, MS, Lieberman, JA. Interrelationships of psychiatric symptom severity, medical comorbidity, and functioning in schizophrenia. Psychiatr Serv 2006; 57 (8): 1102–1109.CrossRefGoogle ScholarPubMed
29.Dixon, L, Postrado, L, Delahanty, J, Fischer, PJ, Lehman, A. The association of medical comorbidity in schizophrenia with poor physical and mental health. J Nerv Ment Dis 1999; 187(8):496–502.CrossRefGoogle ScholarPubMed
30.Mackell, JA, Harrison, DJ, McDonnell, DD. Relationship between preventative physical health care and mental health in individuals with schizophrenia: a survey of caregivers. Ment Health Serv Res 2005: 7(4): 225–228.CrossRefGoogle ScholarPubMed
31. A Vision for Change. Report of the expert group on mental health policy. Government of Ireland Department of Health and Children 2006. Available at www.dohc.ie/publications/pdf/visionJor_change.pdf?direct=1Google Scholar
32.Copty, M. Mental Health in Primary Care. South Western Area Health Board report 2004. Available at www.icgp.ie/assets/70/E2A70C5B-9E71-44C5-A8125BC329598B25_document/SWAHB%20report.pdfGoogle Scholar
33.Copty, M. Mental Health in Primary Care Annual Report 2006. Available at www.icgp.ie/index.cfm/loc/6-9-4/articleld/386E45B9-AA3A-9FEC-160C23ED2279D7EB.htmGoogle Scholar
34. Quality and Fairness: A Health System for You. A Health Strategy. Government of Ireland Department of Health and Children 2001. Available at www.dohc.ie/publications/pdf/strategy.pdf?direct=1Google Scholar
35. Mental Health Act 2001. Available at www.irishststutebook.ie/2001/en/act/pub/0025/index.htmlGoogle Scholar
36. Mental Health Act 2001 (Aproved Centres) Regulations 2006. Available at www.mhcirl.ie/act/Mental%20Health%Act%202001%20(Approved%20Centres)%20Regulations%202006.pdfGoogle Scholar
37.Whitford, DL, Copty, M. General practice in Ireland: are we equipped to manage mental health? Ir J Psych Med 2005 22(2): 40–41.CrossRefGoogle ScholarPubMed
38.Copty, M, Whitford, DL. Mental health in general practice: assessment of current state and future needs. Ir J Psych Med 2005 22(3): 83–86.CrossRefGoogle ScholarPubMed
39.Feeney, L, Mooney, M. Atypical antipsychotic monitoring in the Kilkenny Mental Health Services. Ir J Psych Med 2005; 22(3): 101–102.CrossRefGoogle ScholarPubMed
40.Feeney, L, Mooney, M. Atypical antipsychotic monitoring: A survey of patient knowledge and experience. Ir J Psych Med 2006; 23(3): 100–102.CrossRefGoogle ScholarPubMed
41. Irish College of Psychiatrists website: www.irishpsychiatry.com/Google Scholar
42. Royal College of Psychiatrists website: www.rcpsych.ac.uk/Google Scholar
43. Response of the Irish Section of the Royal College of Psychiatrists to Schizophrenia Ireland survey. Available at www.irishpsychiatry.com/press5.htmlGoogle Scholar
44. Houses of the Oireachtas Joint Committee on Health and Children. Eighth Report. The Adverse Side Effects of Pharmaceuticals. April 2007. Available at www.oireachtas.ie/documents/committees29thdail/committeereports2007/side-effects.pdfGoogle Scholar
45.Dinan, TG (editor). Schizophrenia and diabetes 2003: an expert consensus meeting. Br J Psychiatry 2004; 184(suppl 47): S53-54; S112–S114.Google Scholar
46.Citrome, L, Yeomans, D. Do guidelines for severe mental illness promote physical health and well-being? J Psychopharmacol 2005; 19(6 Suppl): 102–109.CrossRefGoogle ScholarPubMed
47. National Institute for Clinical Excellence (NICE). Schizophrenia: core interventions in the treatment and management of schizophrenia in primary and secondary care. Clinical Guideline 1. 2002. Available at www.nice.org.ukGoogle Scholar
48. UK Department of Health. PRODIGY guidance-schizophrenia. 2004. Available at www.prodigy.nhs.ukGoogle Scholar
49.Goodwin, GM for the Consensus Group of the British Association for Psychopharmacology. Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association of Psychopharmacology. J Psychopharmacol 2003; 17(2): 149–173.CrossRefGoogle ScholarPubMed
50.National Institute for Clinical Excellence (NICE). Bipolar disorder-new drugs: Guidance. Technology Appraisal 66. 2003. Available at www.nice.org.ukGoogle Scholar
51.National Institute for Clinical Excellence (NICE). Bipolar disorder: The management of bipolar disorder in adults, children and adolescents, in primary and secondary care. Clinical Guideline 38, 2006. Available at www.nice.org.ukGoogle Scholar
52.Thompson, C. The use of high-dose antipsychotic medication. B J Psychiatry 1994; 164:448–458.CrossRefGoogle ScholarPubMed
53. Consensus statement on high dose antipsychotic medication. Royal College of Psychiatrists London. Council Report CR138: May 2006. Available at http://www.rcpsych.ac.uk/files/pdfversion/CR138.pdfGoogle Scholar
54. Scoping Group on Physical Health in Mental Health. Royal College of Psychiatrists 2008. Available at http://www.rcpsych.ac.uk/pdf/PHYSICAL%20HEALTH%20IN%20MENTAL%20HEALTH%20-%20service%20specific%208tandards.pdfGoogle Scholar
55. Good Psychiatric Practice (Second Edition). Royal College of Psychiatrists London. Council Report CR125. November 2004. Available at http://www.rcpsych.ac.uk/files/pdfver8ion/cr125.pdfGoogle Scholar
56.Taylor, D, Kerwin, R, Paton, C (Eds). The Maudsley 2005-2006 Prescribing Guidelines 8th Edition. Oxford, Taylor & Francis.Google Scholar
57.Bazire, S. Psychotropic Drug Directory 2005. The professionals pocket handbook & aide memoire. Salisbury, Fivepin.Google Scholar
58. British Medical Association & Royal Pharmaceutical Society of Great Britain. British National Formulary. 2006. Also available online at http://www.pharmpress.comGoogle Scholar
59. MIMS Ireland 2006. Dublin, Medical Publications (Ireland) Ltd. Circulated monthly free to medical practitioners in Ireland.Google Scholar
60.American Diabetes Association; American Psychiatric Association; American Association of Clinical Endocrinologists; North American Association for the Study of Obesity. Consensus development conference on antipsychotic drugs and obesity and diabetes. J Clin Psychiatry. 2004; 65(2):267–72.Google Scholar
61.Lehman, AF, Lieberman, JA, Dixon, LB, McGlashan, TH, Miller, AL, Perkins, DO, Kreyenbuhl, J; American Psychiatric Association; Steering Committee on Practice Guidelines. Practice guideline for the treatment of patients with schizophrenia, second edition. Am J Psychiatry. 2004; 161(2 Suppl):1–56. Available free at http://www.psych.org/psych_pract/treatg/pg/Schizophrenia2ePG_05-15-06.pdfGoogle Scholar
62.Buckley, PF, Miller, DD, Singer, B, Arena, J, Stirewalt, EM. Clinicians' recognition of the metabolic adverse effects of antipsychotic medications. Schizophr Res. 2005; 79(2–3): 281–288.CrossRefGoogle ScholarPubMed
63. See: Strategies to Integrate Physical Health Care Into Mental Health. J Clin Psychiatry 2007; 68 (suppl 4): 1–54.Google Scholar
64.Ohlsen, Rl, Peacock, G, Smith, S. Developing a service to monitor and improve physical health in people with serious mental illness. J Psychiatr Ment Health Nurs. 2005; 12(5):614–619.CrossRefGoogle ScholarPubMed
65.Wright, CA, Osborn, DP, Nazareth, I, King, MB. Prevention of coronary heart disease in people with severe mental illnesses: a qualitative study of patient and professionals' preferences for care. BMC Psychiatry. 2006; 6:16.CrossRefGoogle ScholarPubMed
66.Lester, H. Current issues in providing primary health care to people with serious mental illness. Int J Psychiatric Med. 2006; 36 (1): 1–12.CrossRefGoogle ScholarPubMed
67.Thielke, S, Vannoy, S, Unützer, J. Integrating mental health and primary care. Prim Care. 2007; 34 (3): 571–592, vii.CrossRefGoogle ScholarPubMed
68.Druss, BG, Rohrbaugh, RM, Levinson, CM, Rosenheck, RA. Integrated medical care for patients with serious psychiatric illness: a randomized trial. Arch Gen Psychiatry. 2001; 58 (9): 861–868.CrossRefGoogle ScholarPubMed
69.McCreadie, RG, Kelly, C, Connolly, M, Williams, S, Baxter, G, Lean, M, Paterson, JR. Dietary improvement in people with schizophrenia: randomised controlled trial. Br J Psychiatry. 2005; 187: 346–351.CrossRefGoogle ScholarPubMed
70.Evins, AE, Cather, C, Rigotti, NA, Freudenreich, O, Henderson, DC, Olm-Shipman, CM, Goff, DC. Two-year follow-up of a smoking cessation trial in patients with schizophrenia: increased rates of smoking cessation and reduction. J Clin Psychiatry. 2004; 65(3): 307–311.CrossRefGoogle ScholarPubMed
71.Hoffmann, VP, Ahl, J, Meyers, A, Schuh, L, Shults, KS, Collins, DM, Jensen, L. Wellness intervention for patients with serious and persistent mental illness. J Clin Psychiatry. 2005; 66(12):1576–1579.CrossRefGoogle ScholarPubMed
72.Richardson, CR, Faulkner, G, McDevitt, J, Skrinar, GS, Hutchinson, DS, Piette, JD. Integrating physical activity into mental health services for persons with serious mental illness. Psychiatr Serv. 2005; 56(3): 324–331.CrossRefGoogle ScholarPubMed